Levi Garraway, MD, PhD, of the Dana Farber Cancer Institute in Boston, is credited with facilitating major advances in our understanding of cancer biology. He discusses the new paradigm of cancer, as a genomic disease which leads to abnormal activation of oncogenes and inactivation of suppressor genes. The implications for therapy, as we match genetic understanding to drugs, may well be revolutionary. Dr. Gary Kohn hosts.
Levi Garraway, MD, PhD, of the Dana Farber Cancer Institute in Boston, is credited with facilitating major advances in our understanding of cancer biology. He discusses the new paradigm of cancer, as a genomic disease which leads to abnormal activation of oncogenes and inactivation of suppressor genes. The implications for therapy, as we match genetic understanding to drugs, may well be revolutionary. Dr. Gary Kohn hosts.
